Zepbound contains tirzepatide, a once-weekly injectable medicine approved in the US for chronic weight management in adults with obesity, or in some adults with overweight who have at least one weight-related medical condition, when used alongside diet and physical activity
At 20 mg/mL, it equals 25 units
Ther Clin Risk Manag 2022;18:95564
From a pharmacokinetic perspective, besides increased gastric emptying, obesity has been suggested to modulate CYP gene expression, and increased fat mass may result in an increased Vd of lipophilic drugs
So when patients switch from smoking to e-cigs or quit marijuana, youd expect to see increased levels of some antipsychotics and antidepressants (Anderson GD et al, Clin Pharmacokinet 2016;55:13531358)
Ozempic puede bajar el riesgo de eventos cardiovasculares serios, como ataque cerebral, infarto o muerte en adultos con diabetes tipo 2 que tambin tienen enfermedades cardacas